Catalyst Pharm Inc (CPRX) Stock Price, Quote & News

Company Profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well...

Industry: Biotechnology

Sector: Healthcare

Phone: 305 420 3200

Website: catalystpharma.com

Address:

355 Alhambra Circle, Suite 801, Coral Gables, United States

111ggg Sep. 12 at 3:43 PM

$CPRX $20 etched in stone.

2 · Reply

StillWaiting101 Sep. 11 at 4:07 PM

$CPRX really would like us to get above $21 to push out of this downtrend and leave no doubt

1 · Reply

DeepDiveStocks Sep. 10 at 10:50 PM

$CPRX On the weekly, we see bearish liquidity is testing LDPM supports! Continued bearish prints may cause the supports to fail, and the next support level is at LDPM-L7 at $15.80 (currently -20%!)

0 · Reply

FiduciaryPrinciples Sep. 10 at 12:01 AM

$CPRX Will really test your patience. I'm still here because I believe patience will pay in the end. Personally, I wouldn't exit sub $25 and at $25, I'd have to really need the money. I think we all agree that this stock is under value, I have 2 emergency funds before I get to this one so odds are im going to ride this out until it's over valued. I've seen worse stocks at $50 and I think we could easily be over $30. In since Nov 2018, average 4.88 ps.

2 · Reply

StillWaiting101 Sep. 9 at 7:11 PM

$CPRX bigger volume green candles, then using small volume to push the price back down, someone isn't ready to let it go

1 · Reply

StillWaiting101 Sep. 9 at 2:19 PM

$CPRX the hunger for red must be sated

0 · Reply

Brianum2011 Sep. 8 at 8:49 PM

$CPRX I bought in because I’m originally from coral gables and had to represent and i like the 5 year chart but it’s been the most doo doo in my portfolio so far…gotta believe it will start to trend up someday

0 · Reply

StillWaiting101 Sep. 8 at 6:55 PM

$CPRX we are allergic to green, every day we yearn for the sweet embrace of red

0 · Reply

StillWaiting101 Sep. 5 at 7:26 PM

$CPRX thats some volume on that candle

2 · Reply

StillWaiting101 Sep. 4 at 8:10 PM

$CPRX don't let this price action distract you from the obvious

1 · Reply

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 26, 2025, 7:12 PM EDT - 18 days ago

UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Aug 25, 2025, 8:03 AM EDT - 19 days ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Aug 7, 2025, 2:21 PM EDT - 5 weeks ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:13 PM EDT - 5 weeks ago

Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update

Aug 6, 2025, 8:03 AM EDT - 5 weeks ago

Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)

Aug 4, 2025, 8:03 AM EDT - 5 weeks ago

Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors

Jul 22, 2025, 8:03 AM EDT - 7 weeks ago

Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025

Jun 11, 2025, 7:08 AM EDT - 3 months ago

Strong Inflows Make Catalyst Stock an Outlier

Jun 11, 2025, 7:00 AM EDT - 3 months ago

20 stocks you should avoid — no matter how well the market does

CORT CRK CRNC DDD LUMN LYV MGPI

Jun 2, 2025, 8:03 AM EDT - 3 months ago

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

May 31, 2025, 5:18 AM EDT - 3 months ago

Catalyst: Solid Business Model Propels Growth For This Buy And Build Pharma

May 8, 2025, 12:02 PM EDT - 4 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:14 PM EDT - 4 months ago

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Apr 30, 2025, 8:03 AM EDT - 4 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Apr 22, 2025, 8:03 AM EDT - 5 months ago

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 8, 2025, 8:06 AM EDT - 5 months ago

Catalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

Mar 26, 2025, 8:12 AM EDT - 6 months ago

Strong Revenue, Drug Performance Lift Catalyst Shares

Mar 11, 2025, 4:05 AM EDT - 6 months ago

Catalyst Pharmaceuticals: Undervalued Future With Multiple Upside Catalysts

Mar 4, 2025, 8:03 AM EST - 6 months ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Mar 3, 2025, 2:39 PM EST - 6 months ago

Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges

Feb 27, 2025, 12:29 PM EST - 7 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 4:13 PM EST - 7 months ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 12, 2025, 8:03 AM EST - 7 months ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Feb 7, 2025, 3:56 PM EST - 7 months ago

Catalyst Remains a Big Money Favorite

Jan 23, 2025, 8:03 AM EST - 8 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Jan 21, 2025, 8:19 AM EST - 8 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

Jan 13, 2025, 8:30 AM EST - 8 months ago

Catalyst Pharmaceuticals: The Stars Align For Flagship FIRDAPSE

Jan 8, 2025, 12:30 PM EST - 8 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

Dec 16, 2024, 8:03 AM EST - 9 months ago

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 25, 2024, 8:03 AM EST - 10 months ago

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500™ List

Nov 13, 2024, 8:03 AM EST - 10 months ago

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

Nov 7, 2024, 10:34 AM EST - 11 months ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:12 PM EST - 11 months ago

Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 22, 2024, 8:03 AM EDT - 11 months ago

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

Oct 8, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts

Oct 1, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024

Sep 24, 2024, 6:00 AM EDT - 1 year ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan

Sep 12, 2024, 1:00 AM EDT - 1 year ago

Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 8:35 AM EDT - 1 year ago

Top 3 Health Care Stocks That May Crash In August

CAH VRNA

Aug 8, 2024, 1:30 PM EDT - 1 year ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:11 PM EDT - 1 year ago

Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

Jul 30, 2024, 10:13 AM EDT - 1 year ago

Top 3 Health Care Stocks You May Want To Dump This Quarter

VRDN VRNA

Jul 24, 2024, 8:05 AM EDT - 1 year ago

Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada

Jul 22, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 17, 2024, 11:57 AM EDT - 1 year ago

These small-cap stocks score highest when screened for quality

CALX CARG CORT GOGO MC MYRG PLMR

May 30, 2024, 1:41 PM EDT - 1 year ago

Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®

May 28, 2024, 8:03 AM EDT - 1 year ago

Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024

May 9, 2024, 10:52 AM EDT - 1 year ago

Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:16 PM EDT - 1 year ago

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

111ggg Sep. 12 at 3:43 PM

$CPRX $20 etched in stone.

2 · Reply

StillWaiting101 Sep. 11 at 4:07 PM

$CPRX really would like us to get above $21 to push out of this downtrend and leave no doubt

1 · Reply

DeepDiveStocks Sep. 10 at 10:50 PM

$CPRX On the weekly, we see bearish liquidity is testing LDPM supports! Continued bearish prints may cause the supports to fail, and the next support level is at LDPM-L7 at $15.80 (currently -20%!)

0 · Reply

FiduciaryPrinciples Sep. 10 at 12:01 AM

2 · Reply

StillWaiting101 Sep. 9 at 7:11 PM

$CPRX bigger volume green candles, then using small volume to push the price back down, someone isn't ready to let it go

1 · Reply

StillWaiting101 Sep. 9 at 2:19 PM

$CPRX the hunger for red must be sated

0 · Reply

Brianum2011 Sep. 8 at 8:49 PM

0 · Reply

StillWaiting101 Sep. 8 at 6:55 PM

$CPRX we are allergic to green, every day we yearn for the sweet embrace of red

0 · Reply

StillWaiting101 Sep. 5 at 7:26 PM

$CPRX thats some volume on that candle

2 · Reply

StillWaiting101 Sep. 4 at 8:10 PM

$CPRX don't let this price action distract you from the obvious

1 · Reply

ConsistencySpike Sep. 4 at 7:37 PM

$CPRX

0 · Reply

Diego6767672 Sep. 4 at 3:48 PM

$CPRX I think we're all fed up with Catalyst's management, but I think the market is overreacting. I'll continue buying with long-term expectations.

0 · Reply

Rantomac Sep. 4 at 2:20 PM

$CPRX Double bottom? Short term but we were here beginning of Aug.! A little volume here and then a bounce back over $20

0 · Reply

StillWaiting101 Sep. 4 at 2:04 PM

$CPRX atleast they didn't give us the illusion of a green day, red out of the gate

2 · Reply

111ggg Sep. 4 at 2:00 PM

$CPRX Managements silence tells me all I need to know. Get out and never look back. It has been a nice 3 year run until this year. Insider selling should have been taken more seriously on my part. My bad. Good luck to all long term holders

2 · Reply